Poster #1 – Development of Luciferase bioluminescent cell lines allows tumor monitoring with the Ivis Imager®
Poster #2 – Characterization of acquired PD1 / PDL1 resistance tumor demonstrates model-dependant mechanisms
Poster #3 – DIACCURATE : DIACC3010, optimized inhibitor of S6 kinase, combined with endocrine therapy, has potent antitumor activity in metastatic or resistant breast cancer
Poster #4 – Resistant colorectal cancer: efficacity study of STC1010 antitumor vaccine associated with standard chemotherapies on MC38 syngeneic model
